A Hyperliquid cryptocurrency address initiated a large long position by purchasing 500 Bitcoin, valued at approximately $34.5 million. The average price for this position was $68,997 per Bitcoin. This significant trade highlights strong bullish sentiment from the address holder, potentially influencing market dynamics. Investors should watch for further activity from this address as it may signal confidence in Bitcoin's price direction.
The Hyperliquid address opened a 500-Bitcoin long position valued at $34.5 million. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Nov 13, 2026 17:21 WIB: out of 50 major cryptocurrencies, 12 rose and 37 fell today. Notable movers include BAL (Balancer) with a 1-day change of +11.14% at Rp16.297, EOS (EOS.IO) up 8.13% at Rp12.649, and ONE (Harmony) down 8.41% at Rp27 with a typical hold time of 153 days and Pluang order activity showing 40% Sell / 60% Buy.
The Philippines solar energy market is projected to grow from 5.43 GW in 2026 to 23.35 GW by 2032, with a CAGR of 27.46%. Growth is fueled by declining costs of solar panels and installation, government-backed renewable energy auctions, and increasin...
Equinor ASA shares will trade ex-dividend on the Oslo Stock Exchange starting November 13, 2026, for the second quarter of 2026. The declared dividend amount is $0.39 per share, payable in USD. This means investors buying shares from this date will n...
China Eastern Airlines signed 23 procurement agreements worth $540 million with 15 suppliers from eight countries at the 9th China International Import Expo in Shanghai. The deals cover aircraft engines, aviation materials, jet fuel, and in-flight ca...
Eramet announced a €500 million share capital increase through a rights issue, offering 6 new shares for every 5 existing shares at €14.49 each. The proceeds will be used to reduce the company's debt and strengthen its balance sheet as part of a prev...
Pasithea Therapeutics announced positive Phase 1/1b results for PAS-004, showing significant reductions in cutaneous neurofibromas (cNF) size by up to 71% with continued treatment and early activity in plexiform neurofibromas (PN). The drug demonstra...
